Luncheon and Monthly Meetings
September 28, Monday
Dr. Hideko Yamauchi – Director of Breast Surgical Oncology at St. Luke’s International Hospital, Tokyo
Breast cancer specialist Dr. Yamauchi gave us a very interesting lecture. She shared current topics on breast cancer, including differences between western countries and Japan. Breast cancer is the most common cancer for women in most countries of all over the world including Japan, although age-specific incidence is different between Japanese women and western population. In Japan, about half of breast cancer patients are diagnosed in their 30-50’s. The implication is that these women, who are a productive force in society, often young mothers. She is passionate about the importance of investigating the socio-economic impacts of the disease and its treatment for cancer survivors and to develop interventions to minimize it. It was inspiring to her about the comprehensive support structure her team is building, including support for the children of breast cancer patients. We learned about the “Angelina Jolie” effect and latest findings on care of hereditary cancers. It was an important update as well as a reminder of how we as a society can discuss breast cancer and what we can do for breast cancer survivors.
Dr. Yamauchi, Director of Breast Surgical Oncology at St. Luke’s International Hospital in Tokyo, received her medical education at Juntendo University in Tokyo, Japan. After she completed a surgical residency at St. Luke’s International Hospital, she underwent extended trainings in the United States as a researcher and instructor at Dana-Farber/Harvard Cancer Center and at Georgetown Lombardi Comprehensive Cancer Center. She also completed a clinical surgical residency and a clinical fellowship at the University of Hawaii, and a clinical fellowship at H. Lee Moffitt Cancer Center & Research Institute. In 2010, she launched herself as Director of the Breast Center of St. Luke’s International Hospital. She has been working at her “home ground” to develop “a living affectionate team” of clinicians, researchers and patients. Her team treats about 1000 newly diagnosed breast cancer patients each year.
If you are not a CWAJ member but would like to attend a luncheon, learn more about CWAJ, or attend an "Information Meeting", please contact Member Activities at email@example.com.